RNS Number : 7822T
Assura PLC
29 November 2021
29 November 2021
Assura plc
Capital Markets Webinar
Today, Assura plc ("Assura") is hosting a Capital Markets webinar for analysts and investors.
The webinar will feature presentations from several members of the management team covering the following topics:
- How our Sustainability and Social Impact strategy, SixbySix, is embedded in our property team
- Our net zero carbon development strategy
- An update on how the primary care market is evolving
- The benefits for Assura from our strategic partnership with Modality, one of the leading primary care at scale providers
No new material trading information will be disclosed.
The event can be viewed at this link at 1.30pm today:
https://webcasting.brrmedia.co.uk/broadcast/612fc1ce12f0cb436ea68fb8
A copy of the presentation will be available on the Assura plc website from 1pm at:
https://www.assuraplc.com/investor-relations/reports-and-presentations
- ENDS -
For more information, please contact:
|
Assura plc
David Purcell, Head of Investor Relations
|
Tel:
01925 420680
Email:
[email protected]
|
|
Finsbury
Gordon Simpson
James Thompson
|
Tel:
0207 251 3801
Email:
[email protected]
|
Notes to Editors
Modality Partnership is an award-winning GP super-partnership that operates primary health care and community services nationally across 49 sites. Further information is available at
www.modalitypartnership.nhs.uk
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at £2,595 million.
Further information is available at
www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
MSCFEDFMMEFSEDF